Cargando…
Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis
Human noroviruses are a leading cause of gastroenteritis worldwide, yet there are no licensed antivirals. There is an urgent need for norovirus therapeutics, particularly for chronic infections in immunocompromised individuals, but also a potential need for prophylactic use in epidemics. Continued r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704654/ https://www.ncbi.nlm.nih.gov/pubmed/26744429 http://dx.doi.org/10.1093/infdis/jiv280 |